2Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation : an analysis based on 8.3 million patients [ J ]. Europace, 2013, 15 (4) : 486-493. doi: 10. 1093/europace/ eus333.
3Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study[J]. Circulation, 2014, 129(8):837-847. doi: 10. 1161/CIRCULATIONAHA. 113. 005119.
4Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the framingham study [ J ]. Stroke, 1991, 22(8) :983-988.
6European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation : the task force for the management of atrial fibrillation of the European Society of Cardiology ( ESC ) [J]. Europace, 2011, 12 (10): 1360-1420. doi: 10. 1093/ europace/euq350.
7January CT, Wann LS, Alpert iS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [ J ]. J Am Coll Cardiol, 2014,64 ( 21 ) : el-76. doi : 10. 1016/j. jaec. 2014.03. 022.
8Pistem R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation : the Euro Heart Survey [ J ]. Chest,2010,138 ( 5 ) : 1093-1100. doi : 10. 1378/chest. 10-0134.
9Sabir IN, Matthews GD, Huang CL. Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice [ J ]. Postgrad Med J,2013,89( 1052 ) :346-351. doi: 10. 1136/postgradmedj- 2012-131386.
10Camm A J, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC guidelines for the management of atrial fibrillation : developed with the special contribution of the European Heart Rhythm Association [ J ]. Europace, 2012,14 ( 10 ) : 1385- 1413.
